<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2020-10-07" version="199">
<accession>P49407</accession>
<accession>B6V9G8</accession>
<accession>O75625</accession>
<accession>O75630</accession>
<accession>Q2PP20</accession>
<accession>Q9BTK8</accession>
<name>ARRB1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Beta-arrestin-1</fullName>
</recommendedName>
<alternativeName>
<fullName>Arrestin beta-1</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="40">Non-visual arrestin-2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ARRB1</name>
<name type="synonym">ARR1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="9753" last="9761">
<title>Molecular analysis of human beta-arrestin-1: cloning, tissue distribution, and regulation of expression. Identification of two isoforms generated by alternative splicing.</title>
<authorList>
<person name="Parruti G."/>
<person name="Peracchia F."/>
<person name="Sallese M."/>
<person name="Ambrosini G."/>
<person name="Masini M."/>
<person name="Rotilio D."/>
<person name="de Blasi A."/>
</authorList>
<dbReference type="PubMed" id="8486659"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A AND 1B)</scope>
<source>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1998-08" db="EMBL/GenBank/DDBJ databases">
<title>Molecular cloning of two isoforms of human beta-arrestin 1.</title>
<authorList>
<person name="Yu Q.M."/>
<person name="Zhou T.H."/>
<person name="Cheng Z.J."/>
<person name="Ma L."/>
<person name="Pei G."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A AND 1B)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2005-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2008-10" db="EMBL/GenBank/DDBJ databases">
<title>Isolation of cDNA coding for Homo sapiens arrestin, beta 1 (ARRB1), transcript variant 2.</title>
<authorList>
<person name="Kaighin V.A."/>
<person name="Martin A.L."/>
<person name="Aronstam R.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1B)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1A)</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="2985" last="2990">
<title>Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2.</title>
<authorList>
<person name="Aragay A.M."/>
<person name="Mellado M."/>
<person name="Frade J.M."/>
<person name="Martin A.M."/>
<person name="Jimenez-Sainz M.C."/>
<person name="Martinez-A C."/>
<person name="Mayor F. Jr."/>
</authorList>
<dbReference type="PubMed" id="9501202"/>
<dbReference type="DOI" id="10.1073/pnas.95.6.2985"/>
</citation>
<scope>INTERACTION WITH CCR2 AND GRK2</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="6831" last="6834">
<title>Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells.</title>
<authorList>
<person name="Kovoor A."/>
<person name="Celver J."/>
<person name="Abdryashitov R.I."/>
<person name="Chavkin C."/>
<person name="Gurevich V.V."/>
</authorList>
<dbReference type="PubMed" id="10066734"/>
<dbReference type="DOI" id="10.1074/jbc.274.11.6831"/>
</citation>
<scope>MUTAGENESIS OF ARG-169</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Science" volume="283" first="655" last="661">
<title>Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.</title>
<authorList>
<person name="Luttrell L.M."/>
<person name="Ferguson S.S.G."/>
<person name="Daaka Y."/>
<person name="Miller W.E."/>
<person name="Maudsley S."/>
<person name="Della Rocca G.J."/>
<person name="Lin F.-T."/>
<person name="Kawakatsu H."/>
<person name="Owada K."/>
<person name="Luttrell D.K."/>
<person name="Caron M.G."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="9924018"/>
<dbReference type="DOI" id="10.1126/science.283.5402.655"/>
</citation>
<scope>INTERACTION WITH ADRB2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="17201" last="17210">
<title>Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors.</title>
<authorList>
<person name="Oakley R.H."/>
<person name="Laporte S.A."/>
<person name="Holt J.A."/>
<person name="Caron M.G."/>
<person name="Barak L.S."/>
</authorList>
<dbReference type="PubMed" id="10748214"/>
<dbReference type="DOI" id="10.1074/jbc.m910348199"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ASSOCIATION WITH ANTAGONIST-STIMULATED GPCRS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Nat. Immunol." volume="1" first="227" last="233">
<title>Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI.</title>
<authorList>
<person name="Barlic J."/>
<person name="Andrews J.D."/>
<person name="Kelvin A.A."/>
<person name="Bosinger S.E."/>
<person name="DeVries M.E."/>
<person name="Xu L."/>
<person name="Dobransky T."/>
<person name="Feldman R.D."/>
<person name="Ferguson S.S."/>
<person name="Kelvin D.J."/>
</authorList>
<dbReference type="PubMed" id="10973280"/>
<dbReference type="DOI" id="10.1038/79767"/>
</citation>
<scope>INTERACTION WITH HCK AND CXCR1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="4277" last="4285">
<title>Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway.</title>
<authorList>
<person name="Braun L."/>
<person name="Christophe T."/>
<person name="Boulay F."/>
</authorList>
<dbReference type="PubMed" id="12464600"/>
<dbReference type="DOI" id="10.1074/jbc.m210120200"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF C5AR1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH C5AR1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="24412" last="24419">
<title>{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.</title>
<authorList>
<person name="Girnita L."/>
<person name="Shenoy S.K."/>
<person name="Sehat B."/>
<person name="Vasilcanu R."/>
<person name="Girnita A."/>
<person name="Lefkowitz R.J."/>
<person name="Larsson O."/>
</authorList>
<dbReference type="PubMed" id="15878855"/>
<dbReference type="DOI" id="10.1074/jbc.m501129200"/>
</citation>
<scope>FUNCTION IN UBIQUITINATION OF IGF1R</scope>
<scope>INTERACTION WITH IGF1R AND MDM2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7807" last="7811">
<title>Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2.</title>
<authorList>
<person name="Ahn S."/>
<person name="Wei H."/>
<person name="Garrison T.R."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="14711824"/>
<dbReference type="DOI" id="10.1074/jbc.c300443200"/>
</citation>
<scope>FUNCTION IN AGTR1-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Cell" volume="123" first="833" last="847">
<title>A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription.</title>
<authorList>
<person name="Kang J."/>
<person name="Shi Y."/>
<person name="Xiang B."/>
<person name="Qu B."/>
<person name="Su W."/>
<person name="Zhu M."/>
<person name="Zhang M."/>
<person name="Bao G."/>
<person name="Wang F."/>
<person name="Zhang X."/>
<person name="Yang R."/>
<person name="Fan F."/>
<person name="Chen X."/>
<person name="Pei G."/>
<person name="Ma L."/>
</authorList>
<dbReference type="PubMed" id="16325578"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.09.011"/>
</citation>
<scope>NUCLEAR FUNCTION IN TRANSCRIPTIONAL REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CREB1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="8041" last="8050">
<title>beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation.</title>
<authorList>
<person name="Barnes W.G."/>
<person name="Reiter E."/>
<person name="Violin J.D."/>
<person name="Ren X.-R."/>
<person name="Milligan G."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="15611106"/>
<dbReference type="DOI" id="10.1074/jbc.m412924200"/>
</citation>
<scope>FUNCTION IN CYTOSKELETAL REARRANGEMENT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="37503" last="37515">
<title>G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers.</title>
<authorList>
<person name="Huettenrauch F."/>
<person name="Pollok-Kopp B."/>
<person name="Oppermann M."/>
</authorList>
<dbReference type="PubMed" id="16144840"/>
<dbReference type="DOI" id="10.1074/jbc.m500535200"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF CCR5</scope>
<scope>INTERACTION WITH CCR5</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Mol. Pharmacol." volume="67" first="78" last="87">
<title>Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking.</title>
<authorList>
<person name="Stalheim L."/>
<person name="Ding Y."/>
<person name="Gullapalli A."/>
<person name="Paing M.M."/>
<person name="Wolfe B.L."/>
<person name="Morris D.R."/>
<person name="Trejo J."/>
</authorList>
<dbReference type="PubMed" id="15475570"/>
<dbReference type="DOI" id="10.1124/mol.104.006072"/>
</citation>
<scope>FUNCTION IN F2LR1-MEDIATED ERK SIGNALING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="1448" last="1453">
<title>Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.</title>
<authorList>
<person name="Ren X.-R."/>
<person name="Reiter E."/>
<person name="Ahn S."/>
<person name="Kim J."/>
<person name="Chen W."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="15671180"/>
<dbReference type="DOI" id="10.1073/pnas.0409534102"/>
</citation>
<scope>FUNCTION IN AVPR2-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Dev. Cell" volume="10" first="329" last="342">
<title>Molecular switches involving the AP-2 beta2 appendage regulate endocytic cargo selection and clathrin coat assembly.</title>
<authorList>
<person name="Edeling M.A."/>
<person name="Mishra S.K."/>
<person name="Keyel P.A."/>
<person name="Steinhauser A.L."/>
<person name="Collins B.M."/>
<person name="Roth R."/>
<person name="Heuser J.E."/>
<person name="Owen D.J."/>
<person name="Traub L.M."/>
</authorList>
<dbReference type="PubMed" id="16516836"/>
<dbReference type="DOI" id="10.1016/j.devcel.2006.01.016"/>
</citation>
<scope>INTERACTION WITH AP2B1</scope>
<scope>MUTAGENESIS OF PHE-388; ASP-390 AND ARG-393</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="1261" last="1273">
<title>beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.</title>
<authorList>
<person name="Shenoy S.K."/>
<person name="Drake M.T."/>
<person name="Nelson C.D."/>
<person name="Houtz D.A."/>
<person name="Xiao K."/>
<person name="Madabushi S."/>
<person name="Reiter E."/>
<person name="Premont R.T."/>
<person name="Lichtarge O."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="16280323"/>
<dbReference type="DOI" id="10.1074/jbc.m506576200"/>
</citation>
<scope>FUNCTION IN ADRB2-MEDIATED ERK SIGNALING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="10856" last="10864">
<title>Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.</title>
<authorList>
<person name="Gesty-Palmer D."/>
<person name="Chen M."/>
<person name="Reiter E."/>
<person name="Ahn S."/>
<person name="Nelson C.D."/>
<person name="Wang S."/>
<person name="Eckhardt A.E."/>
<person name="Cowan C.L."/>
<person name="Spurney R.F."/>
<person name="Luttrell L.M."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="16492667"/>
<dbReference type="DOI" id="10.1074/jbc.m513380200"/>
</citation>
<scope>FUNCTION IN PTH1R-MEDIATED ERK SIGNALING</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="J. Immunol." volume="176" first="7039" last="7050">
<title>Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation.</title>
<authorList>
<person name="McLaughlin N.J."/>
<person name="Banerjee A."/>
<person name="Kelher M.R."/>
<person name="Gamboni-Robertson F."/>
<person name="Hamiel C."/>
<person name="Sheppard F.R."/>
<person name="Moore E.E."/>
<person name="Silliman C.C."/>
</authorList>
<dbReference type="PubMed" id="16709866"/>
<dbReference type="DOI" id="10.4049/jimmunol.176.11.7039"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF PTAFR</scope>
<scope>FUNCTION IN THE P38 MAPK SIGNALING PATHWAY</scope>
<scope>FUNCTION IN ACTIN BUNDLE FORMATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PTAFR AND MAP2K3</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Nat. Immunol." volume="7" first="139" last="147">
<title>Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling.</title>
<authorList>
<person name="Wang Y."/>
<person name="Tang Y."/>
<person name="Teng L."/>
<person name="Wu Y."/>
<person name="Zhao X."/>
<person name="Pei G."/>
</authorList>
<dbReference type="PubMed" id="16378096"/>
<dbReference type="DOI" id="10.1038/ni1294"/>
</citation>
<scope>FUNCTION IN TLR/IL-1 RECEPTOR SIGNALING</scope>
<scope>INTERACTION WITH TRAF6</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Pigment Cell Res." volume="19" first="125" last="135">
<title>The melanosomal/lysosomal protein OA1 has properties of a G protein-coupled receptor.</title>
<authorList>
<person name="Innamorati G."/>
<person name="Piccirillo R."/>
<person name="Bagnato P."/>
<person name="Palmisano I."/>
<person name="Schiaffino M.V."/>
</authorList>
<dbReference type="PubMed" id="16524428"/>
<dbReference type="DOI" id="10.1111/j.1600-0749.2006.00292.x"/>
</citation>
<scope>INTERACTION WITH GPR143</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="J. Cell Sci." volume="120" first="1723" last="1732">
<title>Src-dependent phosphorylation of beta2-adaptin dissociates the beta-arrestin-AP-2 complex.</title>
<authorList>
<person name="Fessart D."/>
<person name="Simaan M."/>
<person name="Zimmerman B."/>
<person name="Comeau J."/>
<person name="Hamdan F.F."/>
<person name="Wiseman P.W."/>
<person name="Bouvier M."/>
<person name="Laporte S.A."/>
</authorList>
<dbReference type="PubMed" id="17456551"/>
<dbReference type="DOI" id="10.1242/jcs.03444"/>
</citation>
<scope>INTERACTION WITH AP2B1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="FASEB J." volume="22" first="2134" last="2141">
<title>Beta-arrestins specifically constrain beta2-adrenergic receptor signaling and function in airway smooth muscle.</title>
<authorList>
<person name="Deshpande D.A."/>
<person name="Theriot B.S."/>
<person name="Penn R.B."/>
<person name="Walker J.K."/>
</authorList>
<dbReference type="PubMed" id="18337459"/>
<dbReference type="DOI" id="10.1096/fj.07-102459"/>
</citation>
<scope>FUNCTION IN BETA-ADRENERGIC RECEPTOR REGULATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="J. Neurochem." volume="106" first="781" last="792">
<title>Post-endocytic fates of delta-opioid receptor are regulated by GRK2-mediated receptor phosphorylation and distinct beta-arrestin isoforms.</title>
<authorList>
<person name="Zhang X."/>
<person name="Wang F."/>
<person name="Chen X."/>
<person name="Chen Y."/>
<person name="Ma L."/>
</authorList>
<dbReference type="PubMed" id="18419762"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2008.05431.x"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF OPRD1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Cell. Signal." volume="21" first="1748" last="1757">
<title>Inhibition of dynamin prevents CCL2-mediated endocytosis of CCR2 and activation of ERK1/2.</title>
<authorList>
<person name="Garcia Lopez M.A."/>
<person name="Aguado Martinez A."/>
<person name="Lamaze C."/>
<person name="Martinez-Alonso C."/>
<person name="Fischer T."/>
</authorList>
<dbReference type="PubMed" id="19643177"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2009.07.010"/>
</citation>
<scope>FUNCTION IN INTERNALIZATION OF CCR2</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="EMBO J." volume="28" first="2706" last="2718">
<title>Beta-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signalling.</title>
<authorList>
<person name="Barthet G."/>
<person name="Carrat G."/>
<person name="Cassier E."/>
<person name="Barker B."/>
<person name="Gaven F."/>
<person name="Pillot M."/>
<person name="Framery B."/>
<person name="Pellissier L.P."/>
<person name="Augier J."/>
<person name="Kang D.S."/>
<person name="Claeysen S."/>
<person name="Reiter E."/>
<person name="Baneres J.L."/>
<person name="Benovic J.L."/>
<person name="Marin P."/>
<person name="Bockaert J."/>
<person name="Dumuis A."/>
</authorList>
<dbReference type="PubMed" id="19661922"/>
<dbReference type="DOI" id="10.1038/emboj.2009.215"/>
</citation>
<scope>PHOSPHORYLATION AT SER-412</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="FEBS Lett." volume="583" first="3310" last="3316">
<title>A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex.</title>
<authorList>
<person name="Li X."/>
<person name="MacLeod R."/>
<person name="Dunlop A.J."/>
<person name="Edwards H.V."/>
<person name="Advant N."/>
<person name="Gibson L.C."/>
<person name="Devine N.M."/>
<person name="Brown K.M."/>
<person name="Adams D.R."/>
<person name="Houslay M.D."/>
<person name="Baillie G.S."/>
</authorList>
<dbReference type="PubMed" id="19782076"/>
<dbReference type="DOI" id="10.1016/j.febslet.2009.09.035"/>
</citation>
<scope>INTERACTION WITH MAP2K4/MKK4</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="J. Leukoc. Biol." volume="86" first="833" last="845">
<title>An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages.</title>
<authorList>
<person name="Cheung R."/>
<person name="Malik M."/>
<person name="Ravyn V."/>
<person name="Tomkowicz B."/>
<person name="Ptasznik A."/>
<person name="Collman R.G."/>
</authorList>
<dbReference type="PubMed" id="19620252"/>
<dbReference type="DOI" id="10.1189/jlb.0908551"/>
</citation>
<scope>FUNCTION IN MIP-1-BETA-STIMULATED CHEMOTAXIS</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="6650" last="6655">
<title>Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2.</title>
<authorList>
<person name="Shenoy S.K."/>
<person name="Modi A.S."/>
<person name="Shukla A.K."/>
<person name="Xiao K."/>
<person name="Berthouze M."/>
<person name="Ahn S."/>
<person name="Wilkinson K.D."/>
<person name="Miller W.E."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="19363159"/>
<dbReference type="DOI" id="10.1073/pnas.0901083106"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP33</scope>
<scope>INTERACTION WITH USP33</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E34192" last="E34192">
<title>Ubiquitination of CXCR7 controls receptor trafficking.</title>
<authorList>
<person name="Canals M."/>
<person name="Scholten D.J."/>
<person name="de Munnik S."/>
<person name="Han M.K."/>
<person name="Smit M.J."/>
<person name="Leurs R."/>
</authorList>
<dbReference type="PubMed" id="22457824"/>
<dbReference type="DOI" id="10.1371/journal.pone.0034192"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ACKR3</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="7169" last="7181">
<title>Beta-arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.</title>
<authorList>
<person name="Watts A.O."/>
<person name="Verkaar F."/>
<person name="van der Lee M.M."/>
<person name="Timmerman C.A."/>
<person name="Kuijer M."/>
<person name="van Offenbeek J."/>
<person name="van Lith L.H."/>
<person name="Smit M.J."/>
<person name="Leurs R."/>
<person name="Zaman G.J."/>
<person name="Vischer H.F."/>
</authorList>
<dbReference type="PubMed" id="23341447"/>
<dbReference type="DOI" id="10.1074/jbc.m112.406108"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ACKR4</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2013" name="J. Cell Sci." volume="126" first="4457" last="4468">
<title>Alpha-arrestin 1 (ARRDC1) and beta-arrestins cooperate to mediate Notch degradation in mammals.</title>
<authorList>
<person name="Puca L."/>
<person name="Chastagner P."/>
<person name="Meas-Yedid V."/>
<person name="Israel A."/>
<person name="Brou C."/>
</authorList>
<dbReference type="PubMed" id="23886940"/>
<dbReference type="DOI" id="10.1242/jcs.130500"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ARRDC1</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2013" name="Sci. Signal." volume="6" first="RA30" last="RA30">
<title>Beta-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6.</title>
<authorList>
<person name="Borroni E.M."/>
<person name="Cancellieri C."/>
<person name="Vacchini A."/>
<person name="Benureau Y."/>
<person name="Lagane B."/>
<person name="Bachelerie F."/>
<person name="Arenzana-Seisdedos F."/>
<person name="Mizuno K."/>
<person name="Mantovani A."/>
<person name="Bonecchi R."/>
<person name="Locati M."/>
</authorList>
<dbReference type="PubMed" id="23633677"/>
<dbReference type="DOI" id="10.1126/scisignal.2003627"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="8990" last="8990">
<title>Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT2 receptor reciprocally modulate their signaling functions.</title>
<authorList>
<person name="Oishi A."/>
<person name="Karamitri A."/>
<person name="Gerbier R."/>
<person name="Lahuna O."/>
<person name="Ahmad R."/>
<person name="Jockers R."/>
</authorList>
<dbReference type="PubMed" id="28827538"/>
<dbReference type="DOI" id="10.1038/s41598-017-08996-7"/>
</citation>
<scope>INTERACTION WITH GPR61; GPR62 AND GPR135</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2006" name="PLoS Biol." volume="4" first="E262" last="E262">
<title>Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly.</title>
<authorList>
<person name="Schmid E.M."/>
<person name="Ford M.G.J."/>
<person name="Burtey A."/>
<person name="Praefcke G.J.K."/>
<person name="Peak-Chew S.-Y."/>
<person name="Mills I.G."/>
<person name="Benmerah A."/>
<person name="McMahon H.T."/>
</authorList>
<dbReference type="PubMed" id="16903783"/>
<dbReference type="DOI" id="10.1371/journal.pbio.0040262"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 383-402 IN COMPLEX WITH AP2B1</scope>
</reference>
<comment type="function">
<text evidence="6 10 11 12 13 14 15 16 17 19 20 23 26 27 29 30 33 34 35 36">Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Involved in internalization of P2RY4 and UTP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 ands subsequent recycling. Involved in the degradation of cAMP by recruiting cAMP phosphodiesterases to ligand-activated receptors. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2). ERK1/2 activated by the beta-arrestin scaffold is largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Recruits c-Src/SRC to ADRB2 resulting in ERK activation. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Inhibits ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Is required for SP-stimulated endocytosis of NK1R and recruits c-Src/SRC to internalized NK1R resulting in ERK1/2 activation, which is required for the antiapoptotic effects of SP. Is involved in proteinase-activated F2RL1-mediated ERK activity. Acts as signaling scaffold for the AKT1 pathway. Is involved in alpha-thrombin-stimulated AKT1 signaling. Is involved in IGF1-stimulated AKT1 signaling leading to increased protection from apoptosis. Involved in activation of the p38 MAPK signaling pathway and in actin bundle formation. Involved in F2RL1-mediated cytoskeletal rearrangement and chemotaxis. Involved in AGTR1-mediated stress fiber formation by acting together with GNAQ to activate RHOA. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. May serve as nuclear messenger for GPCRs. Involved in OPRD1-stimulated transcriptional regulation by translocating to CDKN1B and FOS promoter regions and recruiting EP300 resulting in acetylation of histone H4. Involved in regulation of LEF1 transcriptional activity via interaction with DVL1 and/or DVL2 Also involved in regulation of receptors other than GPCRs. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN. Binds phosphoinositides. Binds inositolhexakisphosphate (InsP6) (By similarity). Involved in IL8-mediated granule release in neutrophils. Required for atypical chemokine receptor ACKR2-induced RAC1-LIMK1-PAK1-dependent phosphorylation of cofilin (CFL1) and for the up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. Involved in the internalization of the atypical chemokine receptor ACKR3. Negatively regulates the NOTCH signaling pathway by mediating the ubiquitination and degradation of NOTCH1 by ITCH. Participates in the recruitment of the ubiquitin-protein ligase to the receptor (PubMed:23886940).</text>
</comment>
<comment type="subunit">
<text evidence="6 9 10 15 16 18 19 21 22 23 24 25 28 32 33 34 36 37 38 39">Monomer. Homodimer. Homooligomer; the self-association is mediated by InsP6-binding. Heterooligomer with ARRB2; the association is mediated by InsP6-binding. Interacts with GPR143. Interacts with ADRB2 (phosphorylated). Interacts with CHRM2 (phosphorylated). Interacts with LHCGR. Interacts with CYTH2 and CASR. Interacts with AP2B1 (dephosphorylated at 'Tyr-737'); phosphorylation of AP2B1 at 'Tyr-737' disrupts the interaction. Interacts (dephosphorylated at Ser-412) with CLTC. Interacts with CCR2 and GRK2. Interacts with CRR5. Interacts with PTAFR (phosphorylated on serine residues). Interacts with CLTC and MAP2K3. Interacts with CREB1. Interacts with TRAF6. Interacts with IGF1R and MDM2. Interacts with C5AR1. Interacts with PDE4D. Interacts with SRC (via the SH3 domain and the protein kinase domain); the interaction is independent of the phosphorylation state of SRC C-terminus. Interacts with TACR1. Interacts with RAF1. Interacts with CHUK, IKBKB and MAP3K14. Interacts with DVL1; the interaction is enhanced by phosphorylation of DVL1. Interacts with DVL2; the interaction is enhanced by phosphorylation of DVL2. Interacts with IGF1R. Associates with MAP kinase p38. Part of a MAPK signaling complex consisting of TACR1, ARRB1, SRC, MAPK1 (activated) and MAPK3 (activated). Part of a MAPK signaling complex consisting of F2RL1, ARRB1, RAF1, MAPK1 (activated) and MAPK3 (activated) (By similarity). Interacts with MAP2K4/MKK4. Interacts with HCK and CXCR1 (phosphorylated). Interacts with ACKR3 and ACKR4. Interacts with ARRDC1; the interaction is direct (PubMed:23886940). Interacts with GPR61, GPR62 and GPR135 (PubMed:28827538).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-11529439">
<id>P63010-2</id>
<label>AP2B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-710484">
<id>O15169</id>
<label>AXIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-397435">
<id>P0DP25</id>
<label>CALM3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-1165705">
<id>P20963</id>
<label>CD247</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-6624559">
<id>P25101</id>
<label>EDNRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-3909604">
<id>P50148</id>
<label>GNAQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-4400880">
<id>Q5JWF2</id>
<label>GNAS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-744239">
<id>Q14749</id>
<label>GNMT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-351506">
<id>P06396</id>
<label>GSN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-351896">
<id>P11142</id>
<label>HSPA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-476263">
<id>Q99683</id>
<label>MAP3K5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-713543">
<id>P53779</id>
<label>MAPK10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-713568">
<id>P45984</id>
<label>MAPK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-346967">
<id>P19338</id>
<label>NCL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-396155">
<id>Q14978</id>
<label>NOLC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-353408">
<id>P14618</id>
<label>PKM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-11526590">
<id>P14859-6</id>
<label>POU2F1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-989143">
<id>P35813</id>
<label>PPM1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-1047039">
<id>O75688</id>
<label>PPM1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-395940">
<id>Q13523</id>
<label>PRPF4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-1055001">
<id>P06702</id>
<label>S100A9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-458376">
<id>Q15208</id>
<label>STK38</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-396105">
<id>Q13428</id>
<label>TCOF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-359854">
<id>P27348</id>
<label>YWHAQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-765538">
<id>P25490</id>
<label>YY1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-740718">
<id>O43298</id>
<label>ZBTB43</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-1051583">
<id>O95218</id>
<label>ZRANB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-743313">
<id>P49407</id>
</interactant>
<interactant intactId="EBI-6480811">
<id>Q7DB77</id>
<label>tir</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="44">Membrane</location>
<location evidence="44">Clathrin-coated pit</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Cell projection</location>
<location evidence="6">Pseudopodium</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
</subcellularLocation>
<text evidence="6">Translocates to the plasma membrane and colocalizes with antagonist-stimulated GPCRs. The monomeric form is predominantly located in the nucleus. The oligomeric form is located in the cytoplasm. Translocates to the nucleus upon stimulation of OPRD1 (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P49407-1</id>
<name>1A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P49407-2</id>
<name>1B</name>
<sequence type="described" ref="VSP_000322"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="6">The [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif mediates interaction the AP-2 complex subunit AP2B1 (By similarity). Binding to phosphorylated GPCRs induces a conformationanl change that exposes the motif to the surface.</text>
</comment>
<comment type="domain">
<text evidence="6">The N-terminus binds InsP6 with low affinity.</text>
</comment>
<comment type="domain">
<text evidence="6">The C-terminus binds InsP6 with high affinity.</text>
</comment>
<comment type="PTM">
<text evidence="31">Constitutively phosphorylated at Ser-412 in the cytoplasm. At the plasma membrane, is rapidly dephosphorylated, a process that is required for clathrin binding and ADRB2 endocytosis but not for ADRB2 binding and desensitization. Once internalized, is rephosphorylated.</text>
</comment>
<comment type="PTM">
<text evidence="28">The ubiquitination status appears to regulate the formation and trafficking of beta-arrestin-GPCR complexes and signaling. Ubiquitination appears to occur GPCR-specific. Ubiquitinated by MDM2; the ubiquitination is required for rapid internalization of ADRB2. Deubiquitinated by USP33; the deubiquitination leads to a dissociation of the beta-arrestin-GPCR complex. Stimulation of a class A GPCR, such as ADRB2, induces transient ubiquitination and subsequently promotes association with USP33.</text>
</comment>
<comment type="similarity">
<text evidence="44">Belongs to the arrestin family.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Arrestin"/>
<text>Arrestin entry</text>
</comment>
<dbReference type="EMBL" id="L04685">
<property type="protein sequence ID" value="AAA35559.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L04685">
<property type="protein sequence ID" value="AAA35558.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF084040">
<property type="protein sequence ID" value="AAC33295.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF084940">
<property type="protein sequence ID" value="AAC34123.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ314865">
<property type="protein sequence ID" value="ABC40724.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ348262">
<property type="protein sequence ID" value="ACI96306.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471076">
<property type="protein sequence ID" value="EAW74962.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003636">
<property type="protein sequence ID" value="AAH03636.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31640.1">
<molecule id="P49407-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44684.1">
<molecule id="P49407-1"/>
</dbReference>
<dbReference type="PIR" id="B46682">
<property type="entry name" value="B46682"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004032.2">
<molecule id="P49407-1"/>
<property type="nucleotide sequence ID" value="NM_004041.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_064647.1">
<molecule id="P49407-2"/>
<property type="nucleotide sequence ID" value="NM_020251.3"/>
</dbReference>
<dbReference type="PDB" id="2IV8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="P/Q=383-402"/>
</dbReference>
<dbReference type="PDB" id="6PWC">
<property type="method" value="EM"/>
<property type="resolution" value="4.90"/>
<property type="chains" value="A=1-393"/>
</dbReference>
<dbReference type="PDB" id="6TKO">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="B=1-418"/>
</dbReference>
<dbReference type="PDB" id="6UP7">
<property type="method" value="EM"/>
<property type="resolution" value="4.20"/>
<property type="chains" value="B=8-355"/>
</dbReference>
<dbReference type="PDBsum" id="2IV8"/>
<dbReference type="PDBsum" id="6PWC"/>
<dbReference type="PDBsum" id="6TKO"/>
<dbReference type="PDBsum" id="6UP7"/>
<dbReference type="SMR" id="P49407"/>
<dbReference type="BioGRID" id="106901">
<property type="interactions" value="274"/>
</dbReference>
<dbReference type="CORUM" id="P49407"/>
<dbReference type="DIP" id="DIP-29979N"/>
<dbReference type="ELM" id="P49407"/>
<dbReference type="IntAct" id="P49407">
<property type="interactions" value="231"/>
</dbReference>
<dbReference type="MINT" id="P49407"/>
<dbReference type="STRING" id="9606.ENSP00000409581"/>
<dbReference type="BindingDB" id="P49407"/>
<dbReference type="ChEMBL" id="CHEMBL1795088"/>
<dbReference type="MoonDB" id="P49407">
<property type="type" value="Curated"/>
</dbReference>
<dbReference type="MoonProt" id="P49407"/>
<dbReference type="TCDB" id="8.A.136.1.1">
<property type="family name" value="the beta-arrestin (arrb) family"/>
</dbReference>
<dbReference type="iPTMnet" id="P49407"/>
<dbReference type="PhosphoSitePlus" id="P49407"/>
<dbReference type="BioMuta" id="ARRB1"/>
<dbReference type="DMDM" id="20141238"/>
<dbReference type="OGP" id="P49407"/>
<dbReference type="EPD" id="P49407"/>
<dbReference type="jPOST" id="P49407"/>
<dbReference type="MassIVE" id="P49407"/>
<dbReference type="MaxQB" id="P49407"/>
<dbReference type="PaxDb" id="P49407"/>
<dbReference type="PeptideAtlas" id="P49407"/>
<dbReference type="PRIDE" id="P49407"/>
<dbReference type="ProteomicsDB" id="56001">
<molecule id="P49407-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="56002">
<molecule id="P49407-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="3527">
<property type="antibodies" value="687 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="408"/>
<dbReference type="Ensembl" id="ENST00000360025">
<molecule id="P49407-2"/>
<property type="protein sequence ID" value="ENSP00000353124"/>
<property type="gene ID" value="ENSG00000137486"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420843">
<molecule id="P49407-1"/>
<property type="protein sequence ID" value="ENSP00000409581"/>
<property type="gene ID" value="ENSG00000137486"/>
</dbReference>
<dbReference type="GeneID" id="408"/>
<dbReference type="KEGG" id="hsa:408"/>
<dbReference type="UCSC" id="uc001owe.3">
<molecule id="P49407-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="408"/>
<dbReference type="DisGeNET" id="408"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000137486.16"/>
<dbReference type="GeneCards" id="ARRB1"/>
<dbReference type="HGNC" id="HGNC:711">
<property type="gene designation" value="ARRB1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000137486">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="107940">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P49407"/>
<dbReference type="OpenTargets" id="ENSG00000137486"/>
<dbReference type="PharmGKB" id="PA59"/>
<dbReference type="eggNOG" id="KOG3865">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000182887"/>
<dbReference type="HOGENOM" id="CLU_033484_1_1_1"/>
<dbReference type="InParanoid" id="P49407"/>
<dbReference type="KO" id="K04439"/>
<dbReference type="OMA" id="LYLAHEQ"/>
<dbReference type="OrthoDB" id="783081at2759"/>
<dbReference type="PhylomeDB" id="P49407"/>
<dbReference type="TreeFam" id="TF314260"/>
<dbReference type="PathwayCommons" id="P49407"/>
<dbReference type="Reactome" id="R-HSA-2122948">
<property type="pathway name" value="Activated NOTCH1 Transmits Signal to the Nucleus"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418555">
<property type="pathway name" value="G alpha (s) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-432720">
<property type="pathway name" value="Lysosome Vesicle Biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-432722">
<property type="pathway name" value="Golgi Associated Vesicle Biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-456926">
<property type="pathway name" value="Thrombin signalling through proteinase activated receptors (PARs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5635838">
<property type="pathway name" value="Activation of SMO"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674135">
<property type="pathway name" value="MAP2K and MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802946">
<property type="pathway name" value="Signaling by moderate kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802948">
<property type="pathway name" value="Signaling by high-kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802955">
<property type="pathway name" value="Paradoxical activation of RAF signaling by kinase inactive BRAF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856825">
<property type="pathway name" value="Cargo recognition for clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9649948">
<property type="pathway name" value="Signaling downstream of RAS mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9656223">
<property type="pathway name" value="Signaling by RAF1 mutants"/>
</dbReference>
<dbReference type="SignaLink" id="P49407"/>
<dbReference type="SIGNOR" id="P49407"/>
<dbReference type="BioGRID-ORCS" id="408">
<property type="hits" value="188 hits in 871 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ARRB1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P49407"/>
<dbReference type="GeneWiki" id="Arrestin_beta_1"/>
<dbReference type="GenomeRNAi" id="408"/>
<dbReference type="Pharos" id="P49407">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P49407"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="P49407">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000137486">
<property type="expression patterns" value="Expressed in lung and 205 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P49407">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P49407">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000785">
<property type="term" value="C:chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005905">
<property type="term" value="C:clathrin-coated pit"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030659">
<property type="term" value="C:cytoplasmic vesicle membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005765">
<property type="term" value="C:lysosomal membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031143">
<property type="term" value="C:pseudopodium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0031691">
<property type="term" value="F:alpha-1A adrenergic receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031692">
<property type="term" value="F:alpha-1B adrenergic receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031701">
<property type="term" value="F:angiotensin receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035612">
<property type="term" value="F:AP-2 adaptor complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990763">
<property type="term" value="F:arrestin family protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035615">
<property type="term" value="F:clathrin adaptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043027">
<property type="term" value="F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004857">
<property type="term" value="F:enzyme inhibitor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0030331">
<property type="term" value="F:estrogen receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031762">
<property type="term" value="F:follicle-stimulating hormone receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001664">
<property type="term" value="F:G protein-coupled receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005096">
<property type="term" value="F:GTPase activator activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005159">
<property type="term" value="F:insulin-like growth factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044325">
<property type="term" value="F:ion channel binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031434">
<property type="term" value="F:mitogen-activated protein kinase kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045309">
<property type="term" value="F:protein phosphorylated amino acid binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031896">
<property type="term" value="F:V2 vasopressin receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042699">
<property type="term" value="P:follicle-stimulating hormone signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002031">
<property type="term" value="P:G protein-coupled receptor internalization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016573">
<property type="term" value="P:histone acetylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070373">
<property type="term" value="P:negative regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034260">
<property type="term" value="P:negative regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032715">
<property type="term" value="P:negative regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032717">
<property type="term" value="P:negative regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045746">
<property type="term" value="P:negative regulation of Notch signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031397">
<property type="term" value="P:negative regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007602">
<property type="term" value="P:phototransduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043280">
<property type="term" value="P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035066">
<property type="term" value="P:positive regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090240">
<property type="term" value="P:positive regulation of histone H4 acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035774">
<property type="term" value="P:positive regulation of insulin secretion involved in cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032092">
<property type="term" value="P:positive regulation of protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002092">
<property type="term" value="P:positive regulation of receptor internalization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035025">
<property type="term" value="P:positive regulation of Rho protein signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034393">
<property type="term" value="P:positive regulation of smooth muscle cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043149">
<property type="term" value="P:stress fiber assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.640">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.840">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000698">
<property type="entry name" value="Arrestin"/>
</dbReference>
<dbReference type="InterPro" id="IPR011021">
<property type="entry name" value="Arrestin-like_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR014752">
<property type="entry name" value="Arrestin_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR011022">
<property type="entry name" value="Arrestin_C-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR017864">
<property type="entry name" value="Arrestin_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR014753">
<property type="entry name" value="Arrestin_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR014756">
<property type="entry name" value="Ig_E-set"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11792">
<property type="entry name" value="PTHR11792"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02752">
<property type="entry name" value="Arrestin_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00339">
<property type="entry name" value="Arrestin_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00309">
<property type="entry name" value="ARRESTIN"/>
</dbReference>
<dbReference type="SMART" id="SM01017">
<property type="entry name" value="Arrestin_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81296">
<property type="entry name" value="SSF81296"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00295">
<property type="entry name" value="ARRESTINS"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0168">Coated pit</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0734">Signal transduction inhibitor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Beta-arrestin-1" id="PRO_0000205194">
<location>
<begin position="1"/>
<end position="418"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SRC" evidence="6">
<location>
<begin position="1"/>
<end position="163"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CHRM2" evidence="6">
<location>
<begin position="45"/>
<end position="86"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TRAF6" evidence="19">
<location>
<begin position="318"/>
<end position="418"/>
</location>
</feature>
<feature type="short sequence motif" description="[DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif">
<location>
<begin position="385"/>
<end position="395"/>
</location>
</feature>
<feature type="binding site" description="Inositol hexakisphosphate" evidence="6">
<location>
<position position="250"/>
</location>
</feature>
<feature type="binding site" description="Inositol hexakisphosphate" evidence="6">
<location>
<position position="255"/>
</location>
</feature>
<feature type="binding site" description="Inositol hexakisphosphate" evidence="6">
<location>
<position position="324"/>
</location>
</feature>
<feature type="binding site" description="Inositol hexakisphosphate" evidence="6">
<location>
<position position="326"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="47"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GRK5" evidence="2 3 4 5 31">
<location>
<position position="412"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 1B." id="VSP_000322" evidence="41 42 43">
<location>
<begin position="334"/>
<end position="341"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive active; enables phosphorylation-independent binding to GPCRs." evidence="8">
<original>R</original>
<variation>E</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AP2B1." evidence="21">
<original>F</original>
<variation>A</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AP2B1." evidence="21">
<original>D</original>
<variation>P</variation>
<location>
<position position="390"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with AP2B1." evidence="21">
<original>R</original>
<variation>A</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA35559/AAA35558." ref="1" evidence="44">
<original>V</original>
<variation>A</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA35559/AAA35558." ref="1" evidence="44">
<original>R</original>
<variation>G</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA35559/AAA35558." ref="1" evidence="44">
<original>K</original>
<variation>E</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC33295/AAC34123." ref="2" evidence="44">
<original>V</original>
<variation>E</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA35559/AAA35558." ref="1" evidence="44">
<original>K</original>
<variation>E</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA35559/AAA35558." ref="1" evidence="44">
<original>Q</original>
<variation>R</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA35559/AAA35558." ref="1" evidence="44">
<original>N</original>
<variation>D</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="384"/>
<end position="394"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IV8"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8BWG8"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10066734"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10973280"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12464600"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14711824"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15475570"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15611106"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15671180"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15878855"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16144840"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16280323"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16325578"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16378096"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16492667"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16516836"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16524428"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16709866"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16903783"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17456551"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18337459"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18419762"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19363159"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19620252"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19643177"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19661922"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19782076"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22457824"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23341447"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23633677"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23886940"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28827538"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9501202"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9924018"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="23886940"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8486659"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="43" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="44" type="ECO:0000305"/>
<sequence length="418" mass="47066" checksum="0A3C135092338D10" modified="2002-03-05" version="2">MGDKGTRVFKKASPNGKLTVYLGKRDFVDHIDLVDPVDGVVLVDPEYLKERRVYVTLTCAFRYGREDLDVLGLTFRKDLFVANVQSFPPAPEDKKPLTRLQERLIKKLGEHAYPFTFEIPPNLPCSVTLQPGPEDTGKACGVDYEVKAFCAENLEEKIHKRNSVRLVIRKVQYAPERPGPQPTAETTRQFLMSDKPLHLEASLDKEIYYHGEPISVNVHVTNNTNKTVKKIKISVRQYADICLFNTAQYKCPVAMEEADDTVAPSSTFCKVYTLTPFLANNREKRGLALDGKLKHEDTNLASSTLLREGANREILGIIVSYKVKVKLVVSRGGLLGDLASSDVAVELPFTLMHPKPKEEPPHREVPENETPVDTNLIELDTNDDDIVFEDFARQRLKGMKDDKEEEEDGTGSPQLNNR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

